OPPI elects Suresh Pattathil as New President
The term, for a period of two years, is effective from 26th September, 2022
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
OPPI
OPPI appoints Vivek Sehgal as new Director General
Sehgal has close to three decades of cross-sectoral experience on policy issues with central/state governments, regulators and…
OPPI-QCI announce Quality Award for Excellent Facility of the year, 2021
The Award is instituted by OPPI in collaboration with QCI to recognise pharmaceutical facilities excelling in quality…
Allergan AbbVie in India to continue high focus on eyecare, neurosciences and aesthetics
Suresh Pattathil, MD & GM, Allergan AbbVie updates Viveka Roychowdhury on the operational and cultural integration of Allergan…
OPPI, IAPO, NATHEALTH, IPA, SEARPharm Forum launch campaign to educate about COVID-19
‘No One is Safe until Everyone is Safe’ campaign aims to support government’s initiatives of protecting people and reducing…
S Sridhar elected as President of OPPI
Sridhar is the MD of Pfizer and is heading Pfizer’s commercial business in India
DCGI calls for suggestions from industry to reduce compliance burden
Pharma associations are likely to submit their recommendations by early next month
OPPI hosts Annual Summit, Healthcare Accelerated
Inaugurated by DV Sadananda Gowda, the theme for the virtual two-day Summit is ‘India’s Healthcare Transformational Journey’
OPPI, FICCI, IPA come together to highlight need for OTC regulations in India
Organise a webinar where experts emphasise the importance of a well-regulated OTC framework to empower patients towards…
Industry urges government to define, implement OTC regulations on priority
A draft report of OTC Drug regulations and the proposed OTC drug list have been submitted to the Drugs Consultative Committee…